Advanced search
Publication Cover
Platelets Volume 16, 2005 - Issue 6
Submit an article Journal homepage
105
Views
42
CrossRef citations to date
0
Altmetric
Research Article

PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy

S. M. G. Smith Cardiovascular Research Unit, University of Sheffield, Clinical Sciences Centre, Northern General Hospital, Sheffield, UK
,
H. M. Judge Cardiovascular Research Unit, University of Sheffield, Clinical Sciences Centre, Northern General Hospital, Sheffield, UK
,
G. Peters AstraZeneca, Wilmington, DE, USA
,
M. Armstrong AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK
,
A. Dupont Service d’Hématologie Biologique, Hôpital Européen Georges Pompidou, Paris, France
,
P. Gaussem Service d’Hématologie Biologique, Hôpital Européen Georges Pompidou, Paris, France
&
R. F. Storey Cardiovascular Research Unit, University of Sheffield, Clinical Sciences Centre, Northern General Hospital, Sheffield, UKCorrespondence[email protected]
 show all
Pages 340-345 | Received 08 Dec 2004, Accepted 14 Dec 2004, Published online: 07 Jul 2009

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Marek Postula, Piotr K. Janicki, Lukasz Milanowski, Justyna Pordzik, Ceren Eyileten, Michal Karlinski, Pawel Wylezol, Marta Solarska, Anna Czlonkowka, Iwona Kurkowska-Jastrzebka, Shigekazu Sugino, Yuka Imamura & Dagmara Mirowska-Guzel. (2017) Association of frequent genetic variants in platelet activation pathway genes with large-vessel ischemic stroke in Polish population. Platelets 28:1, pages 66-73.
Read now
Lukasz Milanowski, Justyna Pordzik, Piotr K Janicki & Marek Postula. (2016) Common Genetic Variants in Platelet Surface Receptors and its Association with Ischemic Stroke. Pharmacogenomics 17:8, pages 953-971.
Read now
Jia-Hui Zhang, Jing Wang, Xiao-Fang Tang, Yi Yao, Yin Zhang, Yuan-Liang Ma, Bo Xu, Run-Lin Gao, Lei Song, Zhan Gao, Jue Chen, Yuan Wu, Yue-Jin Yang, Xian-Min Meng & Jin-Qing Yuan. (2016) Effect of platelet receptor gene polymorphisms on outcomes in ST-elevation myocardial infarction patients after percutaneous coronary intervention. Platelets 27:1, pages 75-79.
Read now
Amber L Beitelshees, Deepak Voora & Joshua P Lewis. (2015) Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics. Pharmacogenomics and Personalized Medicine 8, pages 43-61.
Read now
Alfi Yasmina, Anthonius de Boer, Olaf H Klungel & Vera HM Deneer. (2014) Pharmacogenomics of Oral Antiplatelet Drugs. Pharmacogenomics 15:4, pages 509-528.
Read now

Articles from other publishers (37)

Emily Michael, Lidija Covic & Athan Kuliopulos. 2022. Cell Penetrating Peptides. Cell Penetrating Peptides 307 333 .
John W. Cole. (2021) F2R Polymorphisms and Clopidogrel Efficacy and Safety . Neurology 96:1, pages 10-11.
Crossref
Yuesong PanRunqi WangqinHao LiYilong WangXia MengS. Claiborne JohnstonTabassome SimonJinxi LinXingquan ZhaoLiping Liu, David WangYongjun Wang. (2021) F2R Polymorphisms and Clopidogrel Efficacy and Safety in Patients With Minor Stroke or TIA . Neurology 96:1.
Crossref
Ming-Ju Tsai, Wei-An Chang, Shu-Fang Jian, Kuo-Feng Chang, Chau-Chyun Sheu & Po-Lin Kuo. (2018) Possible mechanisms mediating apoptosis of bronchial epithelial cells in chronic obstructive pulmonary disease – A next-generation sequencing approach. Pathology - Research and Practice 214:9, pages 1489-1496.
Crossref
Aristotelis Chatziioannou, Panagiotis Georgiadis, Dennie G. Hebels, Irene Liampa, Ioannis Valavanis, Ingvar A. Bergdahl, Anders Johansson, Domenico Palli, Marc Chadeau-Hyam, Alexandros P. Siskos, Hector Keun, Maria Botsivali, Theo M. C. M. de Kok, Almudena Espín Pérez, Jos C. S. Kleinjans, Paolo Vineis, Soterios A. Kyrtopoulos, Ralph Gottschalk, Danitsja van Leeuwen, Leen Timmermans, Benedetta Bendinelli, Rachel Kelly, Roel Vermeulen, Lutzen Portengen, Fatemeh Saberi-Hosnijeh, Beatrice Melin, Göran Hallmans, Per Lenner, Toby J. Athersuch, Manolis Kogevinas, Euripides G. Stephanou, Antonis Myridakis, Lucia Fazzo, Marco De Santis, Pietro Comba, Hannu Kiviranta, Panu Rantakokko, Riikka Airaksinen, Päivi Ruokojärvi, Mark Gilthorpe, Sarah Fleming, Thomas Fleming, Yu-Kang Tu, Bo Jonsson, Thomas Lundh, Wei J. Chen, Wen-Chung Lee, Chuhsing Kate Hsiao, Kuo-Liong Chien, Po-Hsiu Kuo, Hung Hung & Shu-Fen Liao. (2017) Blood-based omic profiling supports female susceptibility to tobacco smoke-induced cardiovascular diseases. Scientific Reports 7:1.
Crossref
Justin R. Hamilton & JoAnn Trejo. (2017) Challenges and Opportunities in Protease-Activated Receptor Drug Development. Annual Review of Pharmacology and Toxicology 57:1, pages 349-373.
Crossref
Jane E. NormanMargaret R. CunninghamMatthew L. JonesMary E. WalkerSarah K. WestburyRichard B. SessionsStuart J. MundellAndrew D. Mumford. (2016) Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking. Arteriosclerosis, Thrombosis, and Vascular Biology 36:5, pages 952-960.
Crossref
Eitan A. Friedman, Luisa Texeira, Jessica Delaney, Peter E. Weeke, Donald R. LynchJr.Jr., Ehab Kasasbeh, Yanna Song, Frank E. HarrellJr.Jr., Josh C. Denny, Heidi E. Hamm, Dan M. Roden & John H. Cleator. (2015) Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention. Journal of Thrombosis and Thrombolysis 41:4, pages 656-662.
Crossref
J. Chandrasekhar & R. Mehran. 2016. Cardiovascular Diseases. Cardiovascular Diseases 25 55 .
Teresa Strisciuglio, Giuseppe Di Gioia, Chiara De Biase, Massimiliano Esposito, Danilo Franco, Bruno Trimarco & Emanuele Barbato. (2015) Genetically Determined Platelet Reactivity and Related Clinical Implications. High Blood Pressure & Cardiovascular Prevention 22:3, pages 257-264.
Crossref
S P Nisar, M L Jones, M R Cunningham, A D Mumford & S J Mundell. (2014) Rare platelet GPCR variants: what can we learn? . British Journal of Pharmacology 172:13, pages 3242-3253.
Crossref
Geneviève Freyburger, Sylvie Labrouche, Christophe Hubert & Frédéric Bauduer. (2017) Haemostaseome-associated SNPs: has the thrombotic phenotype a greater influence than ethnicity?. Thrombosis and Haemostasis 113:01, pages 66-76.
Crossref
Julie H. Oestreich, Steven R. Steinhubl, Suellen P. Ferraris, Charles D. Loftin & Wendell S. Akers. (2014) Effect of genetic variation in P2Y12 on TRAP-stimulated platelet response in healthy subjects. Journal of Thrombosis and Thrombolysis 38:3, pages 372-379.
Crossref
Manuela PlatéPhillippa J. LawsonMichael R. HillJennifer K. Quint, Meena Kumari, Geoffrey J. LaurentJadwiga A. Wedzicha, Rachel C. ChambersJohn R. Hurst. (2014) Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations. American Journal of Physiology-Lung Cellular and Molecular Physiology 307:4, pages L311-L316.
Crossref
Y.M. Patel, M. Lordkipanidzé, G.C. Lowe, S.P. Nisar, K. Garner, J. Stockley, M.E. Daly, M. Mitchell, S.P. Watson, S.K. Austin & S.J. Mundell. (2014) A novel mutation in the P2Y12 receptor and a function‐reducing polymorphism in protease‐activated receptor 1 in a patient with chronic bleeding. Journal of Thrombosis and Haemostasis 12:5, pages 716-725.
Crossref
Robert F. Storey, Jayaprakash Kotha, Susan S. Smyth, David J. Moliterno, Tyrus L. Rorick, Tiziano Moccetti, Marco Valgimigli, Jean Pierre Dery, Jan H. Cornel, Gregory S. Thomas, Kurt Huber, Robert A. Harrington, Edward Hord, Heather M. Judge, Edmond Chen, John Strony, Kenneth W. Mahaffey, Pierluigi Tricoci, Richard C. Becker & Lisa K. Jennings. (2017) Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. Thrombosis and Haemostasis 111:05, pages 883-891.
Crossref
Tobias Geisler, Elke Schaeffeler, Elke Schaeffeler, Meinrad Gawaz & Matthias Schwab. (2017) Genetic variation of platelet function and pharmacology: An update of current knowledge. Thrombosis and Haemostasis 110:11, pages 876-887.
Crossref
Alf-Åge R. Pettersen, Harald Arnesen, Trine B. Opstad, Vibeke Bratseth & Ingebjørg Seljeflot. (2012) Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease. Thrombosis Research 130:3, pages 424-428.
Crossref
Deepak Voora & Geoffrey S. Ginsburg. (2012) Clinical Application of Cardiovascular Pharmacogenetics. Journal of the American College of Cardiology 60:1, pages 9-20.
Crossref
Thomas Cuisset, Pierre-Emmanuel Morange & Marie-Christine Alessi. (2011) Recent advances in the pharmacogenetics of clopidogrel. Human Genetics 131:5, pages 653-664.
Crossref
Jochen D. Muehlschlegel, Tjörvi E. Perry, Kuang‐Yu Liu, Amanda A. Fox, Shane A. Smith, Peter Lichtner, Charles D. Collard, Stanton K. Shernan, John H. Hartwig, Simon C. Body & Karin M. Hoffmeister. (2012) Polymorphism in the protease‐activated receptor‐4 gene region associates with platelet activation and perioperative myocardial injury. American Journal of Hematology 87:2, pages 161-166.
Crossref
Tariq Ahmad, Deepak Voora & Richard C. Becker. (2011) The pharmacogenetics of antiplatelet agents: towards personalized therapy?. Nature Reviews Cardiology 8:10, pages 560-571.
Crossref
Andrea Kopp Lugli, Martin M. Brown, Jan Steffel, Linda Büchi, Dorothee Förnzler, Annabelle Dupont, Pascale Gaussem, Marc Forestier & Juerg H. Beer. (2011) Platelet receptor gain-of-function single nucleotide polymorphisms in carotid and vertebral stenosis patients. Journal of Thrombosis and Thrombolysis 32:2, pages 215-222.
Crossref
Deepak Voora, John Horton, Svati H. Shah, Linda K. Shaw & L. Kristin Newby. (2011) Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use. American Heart Journal 162:1, pages 166-172.e1.
Crossref
Mukesh Singh, Bipin Thapa & Rohit Arora. (2010) Clopidogrel Pharmacogenetics and Its Clinical Implications. American Journal of Therapeutics 17:3, pages e66-e73.
Crossref
Raute Sunder-Plassmann & Christine Mannhalter. (2010) Pharmacogenetics guided anticoagulation. Clinical Chemistry and Laboratory Medicine 48.
Crossref
Dominick J. Angiolillo & José Luis Ferreiro. (2010) Platelet Adenosine Diphosphate P2Y12 Receptor Antagonism: Benefits and Limitations of Current Treatment Strategies and Future Directions. Revista Española de Cardiología (English Edition) 63:1, pages 60-76.
Crossref
Dominick J. Angiolillo & José Luis Ferreiro. (2010) Inhibición del receptor plaquetario P2Y12 de adenosina difosfato plaquetario: efectos beneficiosos y limitaciones de las estrategias terapéuticas actuales y perspectivas futuras. Revista Española de Cardiología 63:1, pages 60-76.
Crossref
Marc Cohen. (2009) Antiplatelet therapy in percutaneous coronary intervention: A critical review of the 2007 AHA/ACC/SCAI guidelines and beyond. Catheterization and Cardiovascular Interventions 74:4, pages 579-597.
Crossref
Francisco Marín, Rocío González-Conejero, Piera Capranzano, Theodore A. Bass, Vanessa Roldán & Dominick J. Angiolillo. (2009) Pharmacogenetics in Cardiovascular Antithrombotic Therapy. Journal of the American College of Cardiology 54:12, pages 1041-1057.
Crossref
Zuzana Motovska, Petr Widimsky, Jan Kvasnicka, Robert Petr, Dana Bilkova, Jaroslava Hajkova, Iuri Marinov, Stanislav Simek & Petr Kala. (2009) High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial. Blood Coagulation & Fibrinolysis 20:4, pages 257-262.
Crossref
Jan Kvasnička, Jaroslava Hájková, Petra Bobčíková, Daniela Dušková, Šárka Poletínová, Veronika Kieferová, Zuzana Zenáhlíková & Ladislav Pecen. (2009) Platelet gene polymorphisms related to atherothrombogenesis and their frequencies in the healthy middle-aged Czech population. Cor et Vasa 51:3, pages 187-193.
Crossref
Lisa K. Jennings. (2009) Variability in Platelet Response to the Antiplatelet Agents Aspirin and Clopidogrel. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 8:1, pages 20-28.
Crossref
Viroj Wiwanitkit. (2007) Mutation-prone points in thrombin receptor. Journal of Thrombosis and Thrombolysis 25:2, pages 190-192.
Crossref
Sofia Ramström, Karin Vretenbrant Öberg, Finn Åkerström, Camilla Enström & Tomas L. Lindahl. (2008) Platelet PAR1 receptor density—Correlation to platelet activation response and changes in exposure after platelet activation. Thrombosis Research 121:5, pages 681-688.
Crossref
Julie A. Johnson & Issam Zineh. 2007. Cardiovascular Genetics and Genomics for the Cardiologist. Cardiovascular Genetics and Genomics for the Cardiologist 250 276 .
Amber L. BeitelsheesHoward L. McLeod. (2006) Clopidogrel Pharmacogenetics. Arteriosclerosis, Thrombosis, and Vascular Biology 26:8, pages 1681-1683.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.